|
Aug 12
|
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche
|
|
Aug 12
|
Markus Rohrwild Appointed New CEO of Gubra in a Planned Succession Process
|
|
Aug 11
|
AbbVie’s upadacitinib raises the bar for alopecia areata
|
|
Aug 11
|
Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth
|
|
Aug 11
|
Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
|
|
Aug 10
|
My 3 Favorite Stocks to Buy Right Now
|
|
Aug 9
|
3 Stocks Retirees Should Absolutely Love
|
|
Aug 8
|
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
|
|
Aug 8
|
Epkinly breaks ground in Phase III FL trial
|
|
Aug 7
|
United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
|
|
Aug 7
|
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical
|
|
Aug 7
|
REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights
|
|
Aug 7
|
REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy
|
|
Aug 6
|
Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029
|
|
Aug 6
|
Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi
|
|
Aug 6
|
Get Ready, JUVÉDERM® Day is Calling!
|
|
Aug 6
|
Hungary's Richter says some US exports face tariff challenges, but flagship drug exempt
|
|
Aug 5
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Aug 5
|
AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?
|
|
Aug 5
|
AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|